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Objective—To describe the development, design and function of an innovative international 
clinical research network for neuroimaging research based in Australia within a joint state health 
service/medical school. This network focuses upon identifying neuroimaging biomarkers for 
neuropsychiatric and neurodegenerative disease.
Method—We describe a case study of the iterative development of the network, identifying 
characteristic features and methods which may serve as potential models for virtual clinical 
research networks. This network was established to analyse clinically–derived neuroimaging data 
relevant to neuropsychiatric and neurodegenerative disease, specifically in relation to subcortical 
brain structures.
Results—The network has harnessed synergies from the individual expertise of the component 
groups, primarily clinical neuroscience researchers, to analyse a variety of clinical data.
Conclusion—AUSSIE is an active virtual clinical research network, analogous to a connectome, 
which is embedded in health care and has produced significant research advancing our 
understanding of neuropsychiatric and neurodegenerative disease through the lens of 
neuroimaging.
Background
Clinical medical researchers in psychiatry and psychiatric neuroscience in Australia working 
in health care settings are generally employed either full-time or part-time in the direct 
provision of care. To develop high quality research programs that are funded by external 
grants schemes generally requires dedicated staffing and time for research which active 
clinicians lack, especially given that schemes such as the NHMRC are highly competitive. 
We describe here one model of clinical research that leverages off the skills of researchers, 
with relatively low infrastructure overheads, largely (but not wholly) in the absence of 
substantive external grants. We hope our research network will be a bootstrap to external 
grant funding.
With the appropriate prospective planning, ethical approval and consent it is possible for 
clinical researchers to collect useful clinical data during their daily practice, and then 
combine this with an interest in structural neuroimaging. We have been able to engage a 
network of collaborative researchers via a connective hub based within the ACT Health 
Service and ANU Medical School. This type of clinical research has been a tradition within 
Sweden, where we commenced our collaborations with the Karolinska Institute and Lund 
University, and also in Australia, at the University of Melbourne, UNSW and UWA.
In parallel, each of the clinical research centres has differential, complementary expertise in 
components of the analysis of structural and functional neuroimaging data. Our 
collaborations with specialist computational neuroscience researchers at University of North 
Carolina Chapel Hill (UNC), University of California Los Angeles (UCLA) and the 
University of Southern California (USC) have greatly expanded our scope of research.
The collaborations are focused around identifying gaps in the literature, specifically with 
relation to subcortical brain structures in order to understand structure-function-symptom 
relationships for the development of future biomarkers of disease. We aim to develop 
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clinical biomarkers that may be used as surrogate outcomes in intervention and treatment 
trials. Studies are specifically designed to harness the required skills for a mutually planned 
and written publication, and a virtual project team is created out of the ensemble of skills in 
our network. The currency of the collaboration is shared publications, access to datasets for 
the projects and cross-centre skill development.
Methods
Description of the network development
The development of the network was iterative and will be described in detail as a case study 
from which we will distil useful principles for other clinical researchers envisaging similar 
research (see Table 1).
The first collaboration was the development of the interest in the role of the striatum as a 
structural component in parallel recurrent corticostriatal circuits subserving cognition, 
emotion and movement1. This was established via design, testing and publication of new 
methods to manually segment the striatum (caudate and putamen) in magnetic resonance 
images by our core team at ANU Medical School in conjunction with UNSW and the 
Karolinska Institute2. This led to measurement of the striatum as a marker of corticostriatal 
circuit integrity in post-traumatic stress disorder3 and frontotemporal lobar degeneration 
(FTLD) at the Karolinska Institute4, and in post-stroke subjects with UNSW5.
Through innovative key collaborators at the Melbourne Neuropsychiatry Centre, Royal 
Melbourne Hospital (MNC), we were able to use advanced computational neuroscience 
shape analysis methodologies developed by colleagues at University of North Carolina, 
Chapel Hill6. This shape analysis allowed us to more accurately quantify between-group and 
within-group correlational differences in the shape of striatum in relation to disease or 
neuropsychiatric disorders with Melbourne Neuropsychiatry Unit on choreacanthocytosis7 
and Karolinska clinical data (FTLD)4, as well as the hippocampus in FTLD8.
Access to a larger clinical dataset at MNC of patients with FTLD and related 
neuropsychiatric disorders led us to explore semi-automated methods9 for striatal 
segmentation with collaborators at UCLA, expanding our network, and allowing us to 
upscale projects in collaboration10.
Together with our key collaborators at Karolinska Institute, we were introduced to clinical 
researchers at Lund University and Skåne University Hospital where the shape analysis 
methods could be applied to studies of progressive supranuclear palsy11. In turn, our 
collaborators at Lund have worked with us on datasets for persons suffering from FTLD and 
further introduced us to other researchers working on pharmacoresistant epilepsy and 
Parkinson disease. Through MNC we applied methods for measurement of mid-sagittal 
pontine to midbrain ratio to adult Niemann-Pick C disease, uncovering a biomarker 
associated with clinical eye movement measures in this neurometabolic disorder12, and also 
studied striatal morphology in eating disorders with researchers from Hospital Clinico San 
Carlos Madrid and Complutense University Madrid.
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Through our collaborators at Karolinska Institute, we were able to access the large European 
Union framework of the Leukoaraiosis and Disability in the Elderly study (LADIS) on age-
related white matter disease. One of our early career researchers undertook a Master’s thesis 
on this dataset13. This published work has enabled us to access the entire LADIS study in a 
new semi-automated analysis project with USC.
Together with our collaborators at MNC and Monash University, we have a joint PhD 
student project on subcortical structural morphology in Huntington disease. We also have a 
senior psychiatry trainee developing a study of Parkinson disease with UWA. We have used 
methods developed by MNC and UCLA to measure the morphology of the corpus callosum 
as a biomarker in FTLD.
A new early career collaborator at UWA has joined our network to develop manual 
segmentation methods to quantify the shape of the thalamus as a key subcortical hub, and is 
in turn collaborating through the network with Lund University and with USC for the shape 
analysis. This is a snapshot of development to this stage.
Through the Australian hub, we are connecting with and through to our US and Swedish 
collaborators. Much of our work has focused upon mapping a subcortical connectome14 with 
the key subcortical brain structures as potential biomarkers for neurodegenerative disease. 
This network has resulted in approximately 20 publications in the last five years, largely 
through the goodwill of the clinical and neuroscience researchers involved.
Developing research capacity
Through the hub at the ANU, we have recruited clinical research students, primarily from 
the graduate medical school program. Medical students at the ANU have a mandatory 
research project as part of their course requirements, and we have hosted more than 20 such 
students over the last 10 years, as well as students progressing to Masters and Doctoral 
studies.
We have trained collaborative researchers connected via the various research hubs in 
structural magnetic resonance imaging research. Together with the MNC, we have hosted 
medical specialist psychiatric researchers from Malaysia and Spain, and facilitated 
exchanges.
We have jointly supervised postgraduate research students across all of our centres and plan 
to expand such co-supervision in future.
Project planning for our research studies
As we are located in different countries and time-zones, our planning is conducted by 
asynchronous communication via email, supplemented by phone-calls and yearly face-to-
face meetings by the network coordinator.
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We have described an outline of the iterative development of a synergistic virtual clinical 
research network running on the proverbial smell of an oily rag through the generous and 
essential contribution of expertise, work and infrastructure from each centre. As such we 
have achieved collaboratively more than we could if we sought to develop in each centre the 
same level of expertise in our research specialities, and expanded our own contacts for 
sharing and developing clinical research ideas. Virtual research networks like ours can be a 
springboard to launch and train clinicians and neuroscience researchers in clinical research 
towards practical research literacy, as well as enhancing capacity for such research in 
healthcare settings. As the Australian hubs of the network are embedded within shared 
public health and university setting, we are an example of a virtual integrated health research 
network, and describe some principles of development in Table 2. Similar, much larger scale 
virtual research networks developed for genetic neuroimaging analysis, such as the 
ENIGMA consortium also exist15. In the international development context, similar virtual 
networks, such as Crisis Mapping, a voluntary, self-assembling association sharing data and 
computational methodology which collaborates with local embedded partners to map 
evolving world crises (disasters, conflict), also exist16.
As with any developmental collaboration, there are strengths and pitfalls of the model, 
which we describe in Table 4.
The next stage in our network development will be necessarily to seek innovative ongoing 
funding to support our projects across and via our respective centres, towards expansion of 
the network to the Asia-Pacific region and further Centres.
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Table 1
Establishing a new collaborative network
• Read broadly and consult with research colleagues in and outside your area of research interest
• Interesting research may involve application of interdisciplinary approaches, or application of established methods in a 
new field, or gathering together rare datasets
• Identify a novel research area that is novel, and not already heavily researched
• Develop an area of research expertise: this is essential for participation in any network – this will take time and 
development from your end – but is a predicate before any collaboration can exist, as you must have skills to contribute 
to a collaboration
• Conduct your own research projects in the area towards initial data-based publications framing your interests and 
displaying your skills
• Identify via the literature and through your current networks potential collaborators
• If possible ask mutual contacts (of both you and the collaborator) to introduce you to new potential collaborators: that 
is, leverage from your networks to build a trusted introduction
• Meet with your potential collaborators in person initially towards discussing a collaborative project: this means you 
need to meet on your collaborator’s turf
• Begin with smaller scale collaborative projects of mutual interest to build relationships
• Discuss in detail plans for workflow and writing for the completion of the project
• Quickly and efficiently produce results from the small project to build trust
• Write and publish results together with your collaborators
• Use completed projects as a springboard to new projects
• See also Tables 2 and 3 for additional details on project and collaborative management, and be aware of strengths and 
pitfalls in Table 4
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Table 2
The principles of our project planning
• Identifying a dataset of interest
• Identifying an interesting clinical question that we wish to explore within the dataset
• Determining the clinical data required (clinical scales, neuropsychology, demographics and neuroimaging)
• Assembling the relevant collaborators from the network
• Agreeing on a draft project plan including publication and encompassing authorship, project leads, relevant roles, 
timelines and outcomes (papers)
• Seeking ethical approval at origin data site, and at locally each involved site before commencement
• Sharing only de-identified imaging and clinical data (origin data site de-identifies data using an anonymised unique ID 
number for each subject for which only the origin has the key) for analysis
• Sharing processed imaging and clinical data analysed as per agreement with origin site and other agreed collaborators
• Coordinating via the central hub at ANU Medical School/ACT Health Directorate of network projects, and logistics 
support from the hub for each centre’s self-run projects needing access to the network
• Recruiting mutually supervised clinical researchers for postgraduate degrees based upon the research projects (Masters, 
PhD)
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Table 3
Principles distilled from the development of the network
Trust and cooperation are fundamental:
• Identify people you can work with and trust.
• Early discussion of a project, the participants and publication authorship details are very important.
• Memoranda of understanding between collaborators can provide a vehicle through which to discuss such issues.
• Choosing collaborators to join the network is informed by those already within the network.
Bringing together a variety of skills and interests:
• Neuroimaging work requires different skill sets, from the skill required to manually trace images through to the higher 
level mathematical and computational skills required to develop semi-automated or automatic algorithms.
• Collaborations may develop from complementary skill sets
Having shared interests in clinical research:
• Collaborators must share research ideas and interests, whilst being flexible enough to accommodate alternative views.
Importance of coordination, logistics and good communication:
• Face to face communication is the ideal.
• Good communication can still occur through other media as long as care is taken with the logistics and technology.
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Table 4
Strengths and Pitfalls of the Model
Strengths Pitfalls
Flexibility to build specific virtual project teams Reliant on close coordination of collaborators: face-to-face communication 
limited by time differences
Independent of specific collaborative funding Collaborators must fund their own infrastructure: long-term network funding 
needed
Local ethical approval at origin site for de-identified data to 
be shared
Ethical approval still needed at each collaborative site may introduce delays
De-identified data, using anonymised unique IDs allows for 
safe data transfer
Imperative to maintain up-to-date databases of anonymised unique IDs, 
especially with prospective studies
De-identified data sent via secure cloud computing services Limited capacity of cloud services and download times
Sharing of processed data for further analyses Database reconciliation and version control critical
Project coordinators work across network Requires vigilant project management and communication by coordinator
Shared student supervision across centres Requires close support of student from primary student supervisor & 
coordination of supervisors
Collaborative write-up of research Delays due to multiple collaborators and required institutional approvals
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